Tue.Sep 24, 2024

article thumbnail

Vertex taps Lonza to help produce global supply of cutting-edge CRISPR therapy Casgevy

Fierce Pharma

With the launch of Casgevy gaining momentum, Vertex Pharmaceuticals is adding another link to its gene-editing therapy supply chain. | Vertex has inked a long-term supply agreement with Swiss CDMO Lonza to crank out global commercial supply of Casgevy. Under the deal, Lonza will produce Casgevy from its cell therapy manufacturing facilities in Geleen in the Netherlands and, eventually, its plant in Portsmouth, New Hampshire.

article thumbnail

Pain Meds, Cell Therapies & More: Vertex Pharma CEO Talks About What’s Next After Cystic Fibrosis

MedCity News

Vertex Pharmaceuticals is known for its cystic fibrosis drugs, but the company aims to diversify with a pipeline that reaches more therapeutic areas. CEO Reshma Kewalramani explained Vertex’s strategy during the World Medical Innovation Forum in Boston. The post Pain Meds, Cell Therapies & More: Vertex Pharma CEO Talks About What’s Next After Cystic Fibrosis appeared first on MedCity News.

Pharma 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Bluebird bio lays off 25% of workforce as gene therapy pioneer struggles to stay afloat

Fierce Pharma

After bluebird bio acknowledged troubles keeping its business operational, the gene therapy biotech is launching a restructuring that will reduce the size of its workforce by about 25%. | After bluebird bio acknowledged troubles keeping its business operational, the gene therapy biotech is launching a restructuring that will reduce the size of its workforce by about 25%, or nearly 100 employees.

293
293
article thumbnail

How AI Humanizes Mental Healthcare

MedCity News

The integration of AI into mental healthcare is more advanced than many realize because it’s not always obvious; frequently, it’s providing support to free up clinicians to spend more time with their patients or to get more patients into treatment. The post How AI Humanizes Mental Healthcare appeared first on MedCity News.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Contract manufacturer PCI pumps $365M+ into US, EU packaging projects

Fierce Pharma

Flush with new business, Philadelphia-based CDMO PCI Pharma Services is blueprinting multiple manufacturing outlays on both sides of the Atlantic. | PCI has “heavily invested” in new drug delivery tech at its Philadelphia headquarters, laid plans for a 545,000-square-foot expansion in Rockford, Illinois, acquired a new packaging and device assembly plant near Dublin, Ireland, and broken ground on another at its CityNorth Dublin campus.

article thumbnail

“PBMs favour high list prices”- Novo Nordisk CEO targets PBMs in US Senate hearing

Pharmaceutical Technology

Coverage for its long-acting insulin, Levamir, dropped from 90% to about 35% when the company dropped its list price by 65%.

124
124

More Trending

article thumbnail

Carrot Fertility, Priority Health Strike Partnership for Reproductive Health Support

MedCity News

Carrot Fertility has partnered with Priority Health to offer two design solutions for fully-funded and self-funded employer groups. These solutions include support for fertility treatment, pregnancy, postpartum care, gestational surrogacy, adoption, menopause and low testosterone. The post Carrot Fertility, Priority Health Strike Partnership for Reproductive Health Support appeared first on MedCity News.

109
109
article thumbnail

AGC Biologics telegraphs layoffs, winds down production operations at Colorado plant

Fierce Pharma

As CDMOs across the industry continue to face pressure from a fluctuating biopharma business environment, AGC Biologics is charting another round of staff cuts and pumping the brakes at one of its | As part of the new restructuring push, AGC will lay off 68 employees at its cell and gene therapy plant in Longmont, Colorado, 17 employees at its commercial mammalian plant in Boulder, Colorado, and 10 employees in Bothell, Washington, according to a Worker Adjustment and Retraining Notification ale

Biopharma 260
article thumbnail

Ipsen crosses EU finish line with Alagille syndrome drug

pharmaphorum

After various twists and turns in the regulator path, Ipsen has secured EU approval for Kayfanda, its treatment for severe itching (pruritus) in patients with the rare liver disease Alagille syndrome (ALGS).Kayfanda (odevixibat) is labeled in the EU to treat cholestatic pruritus – itching caused by impaired bile formation or flow – in children aged six months and over with ALGS, a disease caused by a genetic mutation that leads to liver damage and jaundice.

Leads 106
article thumbnail

Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar

Fierce Pharma

Three months after a federal judge in West Virginia sided with Regeneron, blocking the market entry of two biosimilars for blockbuster eye disease drug Eylea, the same judge has rejected the c | Three months after a federal judge in West Virginia sided with Regeneron, blocking the market entry of two biosimilars for blockbuster eye disease drug Eylea, the same judge has rejected the company’s attempt to block Amgen’s Eylea biosimilar.

Marketing 249
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Iterum’s oral sulopenem acceptance hinges on antibiotic stewardship efforts

Pharmaceutical Technology

Iterum Therapeutics faces a mixed reception for its therapy for uncomplicated urinary tract infections (UTIs) as experts raise concerns about antibiotic resistance.

94
article thumbnail

With Novo CEO on the hot seat at Senate hearing, PBMs and insurance concerns get the spotlight

Fierce Pharma

When government officials and politicians scrutinize high U.S. drug prices, the role of insurers and pharmacy benefit managers (PBMs) often commands at least some of the attention. | At the Senate committee hearing on Novo Nordisk's prices for Ozempic and Wegovy, debate around insurance coverage and pharmacy benefit managers took up much of the conversation.

Insurance 239
article thumbnail

EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPA

Pharmaceutical Technology

The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis (EGPA).

104
104
article thumbnail

Ahead of adcomm, FDA challenges broad use of PD-1 drugs in stomach cancer patients

Fierce Pharma

The FDA is having second thoughts about the broad labels it has granted PD-1 inhibitors in newly diagnosed stomach cancer, questioning whether restrictions should be placed on products from Bristol | The FDA is having second thoughts about the broad labels it has granted PD-1 inhibitors in newly diagnosed stomach cancer, questioning whether restrictions should be placed on products from Bristol Myers Squibb, Merck & Co. and BeiGene.

FDA 220
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

EC authorises LEO Pharma Anzupgo cream for chronic hand eczema

Pharmaceutical Technology

The EC has granted marketing authorisation to LEO Pharma’s Anzupgo cream for treating adults with moderate to severe chronic hand eczema.

Pharma 98
article thumbnail

The Long Road to Adoption: What Founders Need to Know Before Breaking into Health Tech

MedCity News

Many great ideas fail because of a fundamental misunderstanding or underestimation of the unique barriers entrenched within healthcare. Here are some key considerations that innovators from non-healthcare backgrounds need to be prepared for. The post The Long Road to Adoption: What Founders Need to Know Before Breaking into Health Tech appeared first on MedCity News.

article thumbnail

Pharmaceutical Packaging Companies in Contract Manufacturing for the Pharmaceutical Industry

Pharmaceutical Technology

Discover the leading Pharmaceutical Packaging Companies, Suppliers & Solutions. Download the free Buyer's Guide today for full details.

article thumbnail

UCB, Biogen lupus drug scores in phase 3 trial

pharmaphorum

UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.Data from the PHOENYCS GO study in moderate to severe SLE patients isn't available yet, but the partners say dapirolizumab pegol achieved a "clinical improvement" in the primary and secondary endpoints, including measures of disease activity and flares.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Telix acquires RLS Radiopharmacies to expand US manufacturing presence

Pharmaceutical Technology

Telix has paid an upfront cost of $230m to acquire 31 licenced radiopharmacies from RLS located across the US.

article thumbnail

Roche launches 'revolutionary' pathogen detection tech

pharmaphorum

Roche launches 12 in one test for respiratory virus, using its 'revolutionary' TAGS tech, that can be used in regular clinical labs

95
article thumbnail

Listening to End Users Is Essential — Here’s How One Digital Health Startup Used Feedback to Revamp Its Platform

MedCity News

Less than a year after its launch, microbiome profiling startup Jona has already given its user interface a makeover as a result of the user feedback it received. If you’re running a successful consumer- or patient-facing startup, acting on user feedback in a timely manner is “absolutely essential,” said Jona CEO Leo Grady. The post Listening to End Users Is Essential — Here’s How One Digital Health Startup Used Feedback to Revamp Its Platform appeared first on MedCity News.

article thumbnail

How Hospitals Can Safely Use AI for Content Creation

Healthcare Success

AI is flooding the internet with low-quality healthcare content that hasn’t been medically reviewed for accuracy. While this can (and should) be viewed as a big problem, it’s also a unique opportunity for hospitals and healthcare systems to stand out as trusted patient resources. We recently sat down with Ed Bennet, Founder of MarTech.Health and a respected voice in healthcare marketing, to discuss how hospitals can use AI tools strategically to outrank unverified AI content.

Medical 62
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Want better cancer treatments? Make biopharma more like Silicon Valley

PharmaVoice

Alicia Zhou brings startup bona fides to the nonprofit Cancer Research Institute to promote defragmentation of the cancer research effort.

article thumbnail

MHRA's AI as medical device pilot opens for applicants

pharmaphorum

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has put out a call for developers of artificial intelligence as a medical device (AIaMD) technology to join its new regulatory pilot.

Medical 66
article thumbnail

Cutting Through the Noise: Best Practices for Pharma Marketers in a Saturated Market

eMediWrite

Marketers in the fiercely competitive pharmaceutical sector of today face a particular difficulty: cutting through the harsh din of a crowded market. Pharma marketers must use innovative, strategic, and data-driven approaches to differentiate their brand from the many others competing for consumers’ attention. These are 5 top strategies for making a name for yourself in the congested pharmaceutical market.

article thumbnail

Ori Biotech, Charles River Cell Therapy Manufacturing Platform Collaboration Yields Promising Results

PharmaTech

The next-generation IRO platform was found to significantly outperform the legacy Prodigy system, showing improvements in cell growth, CAR+ cell yield, and overall efficiency.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Enhancing Patient Healthcare with AI Chatbots

Referral MD

Healthcare has come a long way since doctors made house calls and gave out lollipops to children. Artificial Intelligence (AI) now plays a vital role in helping people find healthcare solutions. One significant factor in determining a city’s quality of life is its access to healthcare. AI Chatbots that connect people to care, whether in urban or rural areas, will improve quality of life, patient engagement, and access to care.

article thumbnail

Battling Burnout: A Leader's Guide to Self-Care

ALULA

Ever feel like you're running on empty? Like you've given 110% to everything and everyone, but somehow, it's still not enough? Welcome to the club, fellow leaders. We've all been there, and let's face it—burnout is a real B.

52
article thumbnail

LogiPharma USA 2024: The National Association of Boards of Pharmacy's PULSE Program

Pharmaceutical Commerce

In an interview with Pharma Commerce Editor Nicholas Saraceno, Mark Karhoff, supply chain & DSCSA consultant, National Association of Boards of Pharmacy, discusses the NABP's PULSE program and how it will support supply chains.

article thumbnail

New collaboration to boost access to innovative microbiome therapies

European Pharmaceutical Review

The European Microbiome Innovation for Health ( EMIH ) and the Microbiome Therapeutics Innovation Group ( MTIG ) have agreed to collaborate to advance the development of microbiome -based products and drugs, broadening patient access to approved microbiome therapeutics. A key priority of the agreement is harmonising regulatory frameworks from different regions, so that a broad range of perspectives are collated.

Pharma 52
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A